NEWS & PRESS RELEASES
First Patient Results Published in JACC Case Reports
JACC Case Reports published the first report of a patient with the SATURN Trans-septal System in the CASSINI EU Early Feasibility Study. A 66-year-old woman with 3+ symptomatic MR patient underwent treatment with the fully percutaneous, transfemoral, transseptal...
Presentation of Saturn at NY Valves – June, 2025
At New York Valves on Friday, June 27th, Dr. Torsten Vahl from Columbia University Irving Medical Center gave an overview of the CASSINI-EU EFS study on Saturn Trans-septal TMVR System, focusing on the one year follow up of the first Trans-septal patient. The...
First-In-Human Trans-Septal Implantation of Saturn Mitral Valve Replacement
We are pleased to announce the first trans-septal clinical trial implant with our proprietary Saturn Transcatheter Mitral Valve. Excellent hemodynamic results are reported for the patient, a 79 year old female suffering from severe mixed (degenerative and functional)...
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
“Learning and innovation go hand in hand.
The arrogance of success is to think that what you did yesterday
will be sufficient for tomorrow.”
William Pollard